News

Drug costs could skyrocket by $51 billion annually with proposed tariffs, report finds
The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...
Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
FDA moves to phase out animal testing, aims for safer and cheaper drug development
The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...
Replacing Artificial Food Dyes Unlikely to Spoil US Packaged Food Firms’ Sales and Profit Prospects
Big picture: Even before stepped-up state regulations, packaged food firms were working to improve the health profile of ...
China Daily Global Edition3d
Debut stem cell therapy pricing released in Hainan
The Boao Lecheng International Medical Tourism Pilot Zone in Hainan province has released pricing for China's first batch of ...
Nature7d
Drug discovery and development articles from across Nature Portfolio
Drug discovery and development together are the complete process of identifying a new drug and bringing it to market. Discovery may involve screening of chemical libraries, identification of the ...
JD Supra7d
The Trump Administration Turns to Drug Pricing: Key Actions and Timelines Under the New EO
President Donald Trump signed an Executive Order (EO) titled, “Lowering Drug Prices by Once Again Putting Americans ...
MedCity News8d
Trump’s Executive Order on Prescription Drug Costs Delivers a Win for Pharma Companies
The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...
FDA’s Roadmap to Reduce Animal Testing Sparks Innovation in Drug Development
The U.S. Food and Drug Administration (FDA) has unveiled a strategic roadmap to reduce reliance on animal testing in preclinical ...
NBC 10 Philadelphia14d
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
The duties could disrupt the complex pharmaceutical supply chain, drive up the prices of drugs ... development in the industry. "We can't breach those agreements, so we have to eat the cost ...
PharmTech15d
Drug Development
Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and ...